CNTG

Europe Clinical Biomarkers Market Analysis and Forecast - GlobeNewswire

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development

CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting

CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights

CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position

CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients

CENTOGENE Receives Nasdaq Non-Compliance Notice

CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders